Exploring the imminent use of AI in developing drugs for diseases like Alzheimer's and cancer, with a focus on expediting the process from years to months. Delving into the future, they dive into the concept of artificial general intelligence (AGI) and its consequences.
This week’s episode is a conversation with Demis Hassabis, the head of Google’s artificial intelligence division. We talk about Google’s latest A.I. models, Gemini and Gemma; the existential risks of artificial intelligence; his timelines for artificial general intelligence; and what he thinks the world will look like post-A.G.I.
Additional listening and reading:
We want to hear from you. Email us at hardfork@nytimes.com. Find “Hard Fork” on YouTube and TikTok.